VivoSim Labs, Inc. (VIVS)

Nasdaq: VIVS · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2010

Grade3.3

◀ Past 1.7● Present 2.7▶ Future 4.8

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in March.

Income statement, by fiscal year, newest first
Fiscal year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Report filed	Jul 14, 2026	Jun 5, 2025	May 31, 2024	Jul 14, 2023	Jun 10, 2022	Jun 15, 2021	May 28, 2020	Jun 3, 2019	May 31, 2018	Jun 7, 2017
Revenue	131,000	144,000	109,000	370,000	1,500,000	0	2,196,000	3,091,000	4,603,000	4,230,000
Cost of revenue	0	5,000	·	·	·	0	328,000	482,000	1,030,000	956,000
Research and development	4,189,000	5,025,000	5,498,000	8,885,000	3,320,000	1,103,000	5,284,000	14,752,000	17,956,000	19,545,000
Selling, general and administrative	7,429,000	7,730,000	9,697,000	9,216,000	9,659,000	15,723,000	18,059,000	15,131,000	20,888,000	22,304,000
Total costs and expenses	11,618,000	12,760,000	15,195,000	18,101,000	12,979,000	16,826,000	23,671,000	30,365,000	39,874,000	42,805,000
Operating income	-11,487,000	-12,616,000	-15,086,000	-17,731,000	-11,479,000	-16,826,000	-21,475,000	-27,274,000	-35,271,000	-38,575,000
Interest expense	12,000	10,000	·	·	·	·	·	·	·	0
Interest and investment income	267,000	140,000	405,000	454,000	8,000	15,000	594,000	705,000	478,000	198,000
Other income (expense), net	·	·	·	0	25,000	6,000	1,535,000	0	-12,000	0
Total non-operating income (expense)	-2,354,000	10,130,000	417,000	474,000	33,000	2,000	2,767,000	642,000	470,000	151,000
Income before income taxes	-13,841,000	-2,486,000	·	·	·	·	·	·	·	·
Income tax expense	2,000	2,000	2,000	2,000	2,000	2,000	2,000	3,000	2,000	23,000
Net income including non-controlling interests	-13,843,000	-2,488,000	-14,671,000	-17,259,000	-11,448,000	-16,826,000	-18,710,000	-26,635,000	-34,803,000	-38,447,000
Net income	-13,843,000	-2,488,000	-14,671,000	-17,259,000	-11,448,000	-16,826,000	-18,710,000	-26,635,000	-34,803,000	-38,447,000
Earnings per share, basic	-5.35	-1.70	-19.25^r	-23.76^b	-15.84^b	·	·	·	·	·
Earnings per share, diluted	-5.35	-1.70	-19.25^r	-23.76^b	-15.84^b	·	·	·	·	·
Earnings per share, basic and diluted	·	·	·	·	-15.84^b	-29.28^b	-33.60^rb	-2.76^b	-3.84^b	-4.68^b
Weighted average shares, basic	2,588,327	1,463,609	762,076^r	726,086^b	725,300^b	·	·	·	·	·
Weighted average shares, diluted	2,588,327	1,463,609	762,076^r	726,086^b	725,300^b	·	·	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	725,300^b	575,167^b	539,817^rb	9,614,992^b	8,936,998^b	8,146,919^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-12 reverse split of Mar 2025.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues

Cost of revenue what it cost to make or buy what it sold

us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfRevenue

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton VIVS · research, not advice